Pharmaron Beijing Co., Ltd.
HKSE: 3759.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Boliang Lou
- Employees
- 21,370
- Headquarters
- Beijing, China
- IPO year
- 2019
- Market cap
- HK$52.8B
- Website
- https://www.pharmaron.com
Loading 3759…
Loading profile data…Frequently asked questions about 3759
What does Pharmaron Beijing Co., Ltd. (3759.HK) do?
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Cl...
Where does 3759.HK trade?
Pharmaron Beijing Co., Ltd. (3759.HK) trades on the Hong Kong Stock Exchange.
What sector is 3759.HK in?
Pharmaron Beijing Co., Ltd. (3759.HK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pharmaron Beijing Co., Ltd.?
Boliang Lou is the chief executive officer of Pharmaron Beijing Co., Ltd. (3759.HK).
Where is Pharmaron Beijing Co., Ltd. headquartered?
Pharmaron Beijing Co., Ltd. is headquartered in China.
Does 3759.HK pay a dividend?
Yes — Pharmaron Beijing Co., Ltd. (3759.HK) paid a trailing twelve-month dividend of HKD 0.22 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 3759.HK go public?
Pharmaron Beijing Co., Ltd. (3759.HK) completed its initial public offering in 2019.